<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01565031</url>
  </required_header>
  <id_info>
    <org_study_id>HULA</org_study_id>
    <nct_id>NCT01565031</nct_id>
  </id_info>
  <brief_title>Prediction of Future Risk in Patients With Controlled Asthma</brief_title>
  <official_title>A Simple Prognostic Score for Future Risk Assessment in Patients With Controlled Asthma Who Undergo a Step-down Guidelines-based Strategy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luis Perez de Llano</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Galdakao-Usansolo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Complexo Hospitalario Universitario de A Coruña</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario Lucus Augusti</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The optimal score to predict unfavourable outcome in well-controlled asthma patients who are
      undergoing a step-wise down-titration of their medication is still lacking. Thus, a study is
      warranted to prospectively develop a prognostic system -easy to perform (suitable for use in
      the clinical rather the research setting)- for asthmatic patients in this clinical setting.

      HYPOTHESIS: A simple score system can accurately predict clinical deterioration of asthma in
      well-controlled patients who are undergoing a step-wise down-titration of their medication
      according to international guidelines.

      METHODS The investigators designed a prospective, multicenter, observational study at five
      centers in cities across Spain.

      The patients group (N = 225) will be evaluated to produce a clinical prediction rule for loss
      of control. The investigators will consider the following variables in the risk factor
      analysis: documented history of previous bronchial obstruction (FEV1/FVC &lt; 70%), coefficient
      of variation (CV) of morning peak expiratory flow (PEF), history of exacerbations, fraction
      of exhaled nitric oxide (FENO), Asthma control test (ACT), ACT item 3 and adherence.

      The score model will be prospectively validated in an independent set of 113 patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Loss of asthma control.</measure>
    <time_frame>12 months</time_frame>
    <description>Loss of control: Either ACT score ≤ 19 or the development of exacerbation or FEV1 decrease ≥20%.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">338</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>controlled asthmatics, down-titration</arm_group_label>
    <description>Adults (age between 18 and 80) with asthma under control (see definitions) during the last 3 months, treated with a combination of ICS and long-acting beta-agonist (LABA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Step-wise down-titration according to international guidelines.</intervention_name>
    <description>The medication will be adjusted according to each patient´s level of control. Depending on the state of control of asthma, the dose will be adjusted up or down (step-up therapy and step-down therapy, respectively) in accordance with GINA.</description>
    <arm_group_label>controlled asthmatics, down-titration</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Well-controlled asthmatics who are regularly under the care of Allergy or Pneumology
        specialists.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (age between 18 and 80.

          -  Asthma under control during the last 3 months.

          -  Treated with a combination of ICS and long-acting beta-agonist (LABA.

          -  Classified as &quot;moderate asthma&quot; by their attending physician.

        Exclusion Criteria:

          -  Active smoking.

          -  Pregnancy.

          -  Treatment with oral corticosteroids, omalizumab or immunotherapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis Perez de Llano, Md, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Servicio Galego de Saude</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luis Perez de Llano, Md, PhD</last_name>
    <phone>34 982296000</phone>
    <email>eremos26@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pneumology Service</name>
      <address>
        <city>Lugo</city>
        <zip>27004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2012</study_first_submitted>
  <study_first_submitted_qc>March 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2012</study_first_posted>
  <last_update_submitted>March 27, 2012</last_update_submitted>
  <last_update_submitted_qc>March 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Lucus Augusti</investigator_affiliation>
    <investigator_full_name>Luis Perez de Llano</investigator_full_name>
    <investigator_title>MD, PhD.</investigator_title>
  </responsible_party>
  <keyword>Asthma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

